Prothena Corp Public (PRTA) Revenue (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Revenue came in at $51.1 million in Q1 2026, up 1706.36% year-on-year from $2.8 million in Q1 2025, and up 243157.14% quarter-over-quarter from $21000.0 in Q4 2025.
Prothena Corp Public (PRTA) Revenue (2012 - 2026) Analysis & Trends
Prothena Corp Public's Revenue history runs 15 years deep, the most recent figure standing at $51.1 million for Q1 2026.
- On a quarterly basis, Revenue rose 1706.36% year-over-year to $51.1 million in Q1 2026; TTM through Mar 2026 was $57.9 million, a 57.99% decrease from a year earlier, with the FY2025 full-year figure at $9.7 million, down 92.83% from the prior year.
- Revenue improved to $51.1 million in Q1 2026 per PRTA's latest filing, from $21000.0 in the prior quarter.
- Across five years, Revenue topped out at $132.0 million in Q2 2024 and bottomed at $21000.0 in Q4 2025.
- The 5-year median for Revenue is $2.2 million (2023), against an average of $20.1 million.
- Across the five-year window, Revenue tumbled 99.37% in 2023 and jumped 5556.0% in 2025, its largest moves.
- Year by year, Revenue stood at $49.9 million in 2022, then tumbled by 99.37% to $316000.0 in 2023, then soared by 571.84% to $2.1 million in 2024, then sank by 99.01% to $21000.0 in 2025, then jumped by 243157.14% to $51.1 million in 2026.
- Per Business Quant, the three latest PRTA Revenue figures stand at $51.1 million (Q1 2026), $21000.0 (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - | 51.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.08 Mn |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 4.42 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 970,000.00 |
| Jun 30, 2024 | 132.01 Mn |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 84.87 Mn |
| Jun 30, 2023 | 4.02 Mn |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | 49.92 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 139.17 Mn |
| Jun 30, 2021 | 60.07 Mn |